Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Ulcerative Colitis: Results from a Phase 2a Clinical Trial

Einat Almon, Yoseph Shaaltiel, Wisam Sbeit, Alex Fich, Doron Schwartz, Mattitiahu Waterman, Mali Szlaifer, Hadar Reuveni, Bat Chen Amit-Cohen, Sari Alon, Raul Chertkoff, Alona Paz, Yaron Ilan

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Ulcerative Colitis: Results from a Phase 2a Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences